Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05144334
What this trial is testing

BTX-1188 in Subjects With Advanced Malignancies

Who this might be right for
Advanced Solid TumorNon Hodgkin LymphomaAcute Myeloid Leukemia
Biotheryx, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT00995332
What this trial is testing

Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

Who this might be right for
Acute Myelogenous Leukemia
University of Bergen 36
Not applicableUnknownNCT04654195
What this trial is testing

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Not applicableStudy completedNCT03113136
What this trial is testing

Examination of Low Wattage and High Wattage E-Cigarettes

Who this might be right for
Smoking, CigaretteSmoking, TobaccoNicotine Dependence+1 more
Ohio State University Comprehensive Cancer Center 372
Post-approval studies (Phase 4)UnknownNCT04628884
What this trial is testing

Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery

Who this might be right for
Anticoagulant Antagonist Toxicity
Fundación Clínica Shaio 136
Testing effectiveness (Phase 2)Study completedNCT00699881
What this trial is testing

Study of Cetuximab to Treat Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 61
Large-scale testing (Phase 3)Not Yet RecruitingNCT07164534
What this trial is testing

A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

Who this might be right for
Uterine Cervical Neoplasm
Tata Memorial Hospital 316
Not applicableStudy completedNCT01070121
What this trial is testing

Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository

Who this might be right for
Rheumatoid Arthritis
University of Alabama at Birmingham 200
Not applicableUnknownNCT05109819
What this trial is testing

Esophagus-sparing Radiotherapy for Metastatic Spinal Cord Compression.

Who this might be right for
Metastatic Spinal Cord CompressionRadiation ToxicityEsophagitis+1 more
Herlev Hospital 200
Not applicableStudy completedNCT04807504
What this trial is testing

Ropivacaine Pharmacokinetics in ESP Blocks

Who this might be right for
Local Anesthetic Systemic ToxicityPainQuality of Recovery
Thomas Jefferson University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06978400
What this trial is testing

Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Blokhin's Russian Cancer Research Center 64
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Large-scale testing (Phase 3)Study completedNCT00536393
What this trial is testing

Treatment of Disseminated High Grade Lymphoma

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 100
Not applicableNot Yet RecruitingNCT07527819
What this trial is testing

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Peter MacCallum Cancer Centre, Australia 75
Not applicableEnded earlyNCT00250146
What this trial is testing

Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease

Who this might be right for
Celiac Disease
Università Politecnica delle Marche 39
Not applicableStudy completedNCT05023096
What this trial is testing

Potential Effects of Electronic Nicotine Delivery System Flavor Regulations on African American Menthol Smokers

Who this might be right for
Electronic Nicotine Delivery System Flavors
Virginia Commonwealth University 71
Testing effectiveness (Phase 2)Study completedNCT03032783
What this trial is testing

A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 51
Not applicableLooking for participantsNCT06033183
What this trial is testing

Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology

Who this might be right for
RadiosensitivityPediatric CancerRadiation Toxicity
Neolys 100
Not applicableStudy completedNCT06778122
What this trial is testing

In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors

Who this might be right for
Cancer SurvivorsCardiotoxicityCardiovascular Toxicity Induced by Antitumoral Drugs
University College, London 10
Testing effectiveness (Phase 2)Study completedNCT01262469
What this trial is testing

Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.

Who this might be right for
Metastatic Breast Cancer70 Years Old Patients and OverAfter One Line of Chemotherapy With Trastuzumab
UNICANCER 4
Next Page